ICD-10-CM Book 2026 Edition
Polyneuropathies and other disorders of the peripheral nervous system (G60-G65)
| Excludes1: |
neuralgia NOS (M79.2)
neuritis NOS (M79.2)
peripheral neuritis in pregnancy (O26.82-)
radiculitis NOS (M54.10)
|
 G60 |
|
Hereditary and idiopathic neuropathy |
| |
 G60.0 |
 |
Hereditary motor and sensory neuropathy |
| |
| Charcot-Marie-Tooth disease | | Déjérine-Sottas disease | | Hereditary motor and sensory neuropathy, types I-IV | | Hypertrophic neuropathy of infancy | | Peroneal muscular atrophy (axonal type) (hypertrophic type) | | Roussy-Levy syndrome |
|
|
| |
| G60.1 |
|
Refsum's disease |
| |
|
|
| |
| G60.2 |
|
Neuropathy in association with hereditary ataxia |
|
| |
| G60.3 |
|
Idiopathic progressive neuropathy |
|
| |
| G60.8 |
|
Other hereditary and idiopathic neuropathies |
| |
| Dominantly inherited sensory neuropathy | | Morvan's disease | | Nelaton's syndrome | | Recessively inherited sensory neuropathy |
|
|
| |
| G60.9 |
|
Hereditary and idiopathic neuropathy, unspecified |
|
| G61 |
|
Inflammatory polyneuropathy |
| |
| G61.0 |
|
Guillain-Barre syndrome |
| |
| Acute (post-)infective polyneuritis | | Miller Fisher Syndrome |
|
|
| |
| G61.1 |
|
Serum neuropathy |
| |
| UseAdditionalCode |
code for adverse effect, if applicable, to identify serum (T50.-)
|
|
|
| |
| G61.8 |
|
Other inflammatory polyneuropathies |
| |
| G61.81 |
|
Chronic inflammatory demyelinating polyneuritis |
| | |
| G61.82 |
|
Multifocal motor neuropathy |
| |
|
| | |
| G61.89 |
|
Other inflammatory polyneuropathies |
| |
| |
| G61.9 |
|
Inflammatory polyneuropathy, unspecified |
|
| G62 |
|
Other and unspecified polyneuropathies |
| |
| G62.0 |
|
Drug-induced polyneuropathy |
| |
| UseAdditionalCode |
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
|
|
|
| |
| G62.1 |
|
Alcoholic polyneuropathy |
|
| |
| G62.2 |
|
Polyneuropathy due to other toxic agents |
| |
| CodeFirst |
(T51-T65) to identify toxic agent
|
|
|
| |
| G62.8 |
|
Other specified polyneuropathies |
| |
| G62.81 |
|
Critical illness polyneuropathy |
| |
|
| | |
| G62.82 |
|
Radiation-induced polyneuropathy |
| |
| UseAdditionalCode |
external cause code (W88-W90, X39.0-) to identify cause
|
|
| | |
| G62.89 |
|
Other specified polyneuropathies |
| |
| |
| G62.9 |
|
Polyneuropathy, unspecified |
| |
|
|
| G63 |
|
Polyneuropathy in diseases classified elsewhere |
| |
| CodeFirst |
underlying disease, such as:
amyloidosis (E85.-)
endocrine disease, except diabetes (E00-E07, E15-E16, E20-E34)
metabolic diseases (E70-E88)
neoplasm (C00-D49)
nutritional deficiency (E40-E64)
|
| Excludes1 |
polyneuropathy (in):
diabetes mellitus (E08-E13 with .42)
diphtheria (A36.83)
infectious mononucleosis complicated by polyneuropathy (B27.0-B27.9 with fifth character 1)
Lyme disease (A69.22)
mumps (B26.84)
postherpetic (B02.23)
rheumatoid arthritis (M05.5-)
scleroderma (M34.83)
systemic lupus erythematosus (M32.19)
|
| nonPrimary |
Yes
|
|
| G64 |
|
Other disorders of peripheral nervous system |
| |
| Disorder of peripheral nervous system NOS |
|
| G65 |
|
Sequelae of inflammatory and toxic polyneuropathies |
| |
| CodeFirst |
condition resulting from (sequela) of inflammatory and toxic polyneuropathies
|
|
| |
| G65.0 |
|
Sequelae of Guillain-Barré syndrome |
|
| |
| G65.1 |
|
Sequelae of other inflammatory polyneuropathy |
|
| |
| G65.2 |
|
Sequelae of toxic polyneuropathy |
|